Inventor · disambiguated record
Steven R. Schow
Also filed as: SCHOW STEVEN · SCHOW STEVEN R
37 granted patents·9 pending applications·768 citations·filing 1981–2023
98Inventor score
Files withTELIK INC15AMERICAN CYANAMID CO7CV THERAPEUTICS INC7VERRICA PHARMACEUTICALS INC5BOULANGER WILLIAM A2
Top patents by PatentIndex Score
46 records- 0194US5866702APurine inhibitors of cyclin dependent kinase 2CV THERAPEUTICS INC·Filed 1996·Granted Feb 2, 1999·142 cites·6 claims
- 0293US6794390B2Purine inhibitors of cyclin dependent kinase 2 & ikappabalphaCV THERAPEUTICS INC·Filed 2001·Granted Sep 21, 2004·43 cites·11 claims
- 0392US7262182B2Sulfonylethyl phosphorodiamidatesTELIK INC·Filed 2005·Granted Aug 28, 2007·12 cites·14 claims
- 0491US6075150Aα-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1998·Granted Jun 13, 2000·96 cites·2 claims
- 0591US5789416AN6 mono heterocyclic substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1996·Granted Aug 4, 1998·107 cites·14 claims
- 0690US10745413B2Commercially viable synthesis of cantharidin and bioactive cantharidin derivativesVERRICA PHARMACEUTICALS INC·Filed 2015·Granted Aug 18, 2020·7 cites·34 claims
- 0788US11168091B2Quantification and preparation of pharmaceutical grade cantharidinVERRICA PHARMACEUTICALS INC·Filed 2016·Granted Nov 9, 2021·4 cites·20 claims
- 0888US6506739B1Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agentsTELIK INC·Filed 2001·Granted Jan 14, 2003·26 cites·20 claims
- 0987US7029695B2Therapeutic compositions containing glutathione analogsTELIK INC·Filed 2001·Granted Apr 18, 2006·31 cites·18 claims
- 1087US5312831AUrethanes and ureas that induce cytokine productionAMERICAN CYANAMID CO·Filed 1993·Granted May 17, 1994·48 cites·25 claims
- 1183US6337338B1Heteroaryl-aryl ureas as IGF-1 receptor antagonistsTELIK INC·Filed 1999·Granted Jan 8, 2002·72 cites·22 claims
- 1282US6781000B1Alpha-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1999·Granted Aug 24, 2004·50 cites·14 claims
- 1381US7192918B2Tripeptide and tetrapeptide sulfonesTELIK INC·Filed 2006·Granted Mar 20, 2007·5 cites·25 claims
- 1478US11702394B2Inhibitors of phospholipid synthesis and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jul 18, 2023·2 cites·16 claims
- 1575US4408059ASpiroketals useful as intermediates in the synthesis of milbemycin and avermectin macrolidesUNIVERSITY PATENTS INC·Filed 1981·Granted Oct 4, 1983·14 cites·6 claims
- 1673US12221452B2Synthesis of cantharidinVERRICA PHARMACEUTICALS INC·Filed 2023·Granted Feb 11, 2025·0 cites·17 claims
- 1772US7129215B2Tripeptide and tetrapeptide thioethersTELIK INC·Filed 2006·Granted Oct 31, 2006·2 cites·24 claims
- 1870US5834487AInhibition of 26S and 20S proteasome by indanonesCV THERAPEUTICS·Filed 1996·Granted Nov 10, 1998·27 cites·11 claims
- 1965US11834412B2Derivatives of aryl hydrocarbon receptor agonistsAZORA THERAPEUTICS INC·Filed 2023·Granted Dec 5, 2023·0 cites·21 claims
- 2065US7071231B2Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2002·Granted Jul 4, 2006·2 cites·20 claims
- 2164US2008159980A1Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyTELIK INC·Filed 2007·Application pending·0 cites
- 2263US5430150ARetroviral protease inhibitorsAMERICAN CYANAMID CO·Filed 1992·Granted Jul 4, 1995·27 cites·6 claims
- 2362US6458998B1Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2000·Granted Oct 1, 2002·1 cites·37 claims
- 2460US2021070771A1Commercially viable synthesis of cantharidin and bioactive cantharidin derivativesVERRICA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2559US6790958B2Purine inhibitors of cyclin dependent kinase 2 & IKBAFiled 2001·Granted Sep 14, 2004·16 cites·3 claims
- 2659US2025188083A1Modulators of Histone Acetyltransferase 1 and Methods of Treatment ThereofUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 2757US2004138140A1Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyTELIK INC·Filed 2003·Application pending·0 cites
- 2856US8093231B2Sulfonylethyl phosphorodiamidatesALLEN DAVID R·Filed 2007·Granted Jan 10, 2012·0 cites·4 claims
- 2955US5616612AUrethanes and ureas that enhance the growth of bone marrow progenitor cellsAMERICAN CYANAMID CO·Filed 1995·Granted Apr 1, 1997·8 cites·3 claims
- 3053US5658945AUrethanes and ureas that induce cytokine productionAMERICAN CYANAMID CO·Filed 1995·Granted Aug 19, 1997·7 cites·3 claims
- 3152US8334266B2Process for and intermediates in the preparation of canfosfamide and its saltsBOULANGER WILLIAM A·Filed 2012·Granted Dec 18, 2012·0 cites·10 claims
- 3252US7109330B2Purine inhibitors of cyclin dependent kinase 2 and IκB-αCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·6 cites·3 claims
- 3352US2020270269A1Synthesis of cantharidinVERRICA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3451US6117887AInhibition of 26S and 20S proteasome by indanonesCV THERAPEUTICS INC·Filed 1998·Granted Sep 12, 2000·8 cites·9 claims
- 3550US8361971B2Tablet formulation of ezatiostatTELIK INC·Filed 2011·Granted Jan 29, 2013·0 cites·22 claims
- 3650US8198247B2Process for and intermediates in the preparation of canfosfamide and its saltsBOULANGER WILLIAM A·Filed 2004·Granted Jun 12, 2012·0 cites·2 claims
- 3746US5633280AUrethanes and ureas that induce cytokine productionAMERICAN CYANAMID CO·Filed 1995·Granted May 27, 1997·4 cites·3 claims
- 3842US6528037B2Method for determining whether a compound is an insulin receptor kinase activatorTELIK INC·Filed 2002·Granted Mar 4, 2003·0 cites·5 claims
- 3942US2014315812A1Amorphous ezatiostat ansolvateTELIK INC·Filed 2012·Application pending·0 cites
- 4040US2011300215A1Tablet formulation of ezatiostatLUM ROBERT T·Filed 2011·Application pending·0 cites
- 4140US2002061927A1Insulin receptor activators for the treatment of metabolic disorders induced by treatment with HIV protease inhibitorsFiled 2001·Application pending·0 cites
- 4239US2012165260A2Crystalline ezatiostat hydrochloride ansolvatePARENT STEPHAN·Filed 2011·Application pending·0 cites
- 4337US6600069B2Benzene tricarboxylic acid derivatives as insulin receptor activatorsTELIK INC·Filed 2001·Granted Jul 29, 2003·0 cites·35 claims
- 4437US5545662AUrethanes and ureas that induce cytokine productionAMERICAN CYANAMID CO·Filed 1994·Granted Aug 13, 1996·1 cites·3 claims
- 4536US6653321B1Naphthylsulfonic acids and related compounds as glucose uptake agonistsTELIK INC·Filed 2000·Granted Nov 25, 2003·0 cites·30 claims
- 4632US5602275AUrethanes and ureas that induce cytokine productionAMERICAN CYANAMID CO·Filed 1995·Granted Feb 11, 1997·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Steven R. Schow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →